About us
We are a committed team of engineers, developers and healthcare professionals dedicated to improve the lives of people with gait impairment
Our Founding Team
Dr. Amalric Ortlieb
-
Co-Founder
-
6 years experience in exoskeleton design
-
PHD Mechanical Engineer EPFL
Fabian Bischof
-
Co-Founder
-
12 years experience in healthcare
-
Master in Business Administration HSG
Our Partners
EPFL is the cradle of the AUTONOMYO's technology and is still a strong R&D partner.
AUTONOMYO is working with the department of neuroscience to further develop and validate its technology.
FAULHABER and AUTONOMYO work jointly to develop the assistive technologies of tomorrow.
MySpace Lab is a research laboratory from the University of Lausanne specialised in the study of neuroscience. MySpace Lab supports AUTONOMYO and its implications with the CHUV hospital.
The Human Brain Project acts as a framework for the development of research in the realms of neuroscience, computing, and brain-related medicine.
The Human Brain Project finances our discovery of neurological patients for understanding and simulating effects of symptoms in functional mobility through a research grant.
Alpine Intuition is an expert in the Artificial Intelligence environment, assisting and providing services to companies that implement AI in their projects. Alpine Intuition is a partner of AUTONOMYO in the Human Brain Project.
Foundation for the support of research on neuromuscular diseases.
FSRMM is the other main contributor to the early financing of AUTONOMYO with ASRIMM.
Pro Infirmis is supporting the integration of AUTONOMYO in the life of people with disabling conditions.
KAPSLY supports entrepreneurs to grow their startups by linking them to professional service agencies. The company elected AUTONOMYO as the first winner of the KAPSLY digital award and provides us with partners for digitalization and product development.
The Foundation for Technological Innovation enhances innovation by providing grants and support to technology startups. FIT provided AUTONOMYO with a grant to develop our technology further, including clinical aspects and proof of concept.